Skip to main content
. 2022 Apr 1;13:820621. doi: 10.3389/fphar.2022.820621

TABLE 3.

Mean availability (%) of insulin and comparator medicines in government- and private-sector hospital pharmacies.

Medicines Public Sector (%) Private Sector (%)
Originator Generic Originator Generic
Human insulin
 Short-acting human 17.5 40.0 60.0 40.0
 Intermediate-acting human 10.0 12.5 52.5 32.5
 Mixed human 37.5 22.5 70.0 57.5
Analog insulin
 Rapid-acting analog 0.0 0.0 47.5 0.0
 Long-acting analog 0.0 0.0 52.5 20.0
 Mixed analog 0.0 0.0 42.5 0.0
Comparator medicines
 Atorvastatin 20 mg 28.6 50.0 60.0 71.4
 Bisoprolol 5 mg 31.4 17.1 65.7 45.7
 Glibenclamide 5 mg 25.7 20.0 60.0 57.1
 Gliclazide 80 mg 28.6 14.3 71.4 5.7
 Metformin 500 mg 40.0 28.6 82.9 42.9